Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-25-000022
Filing Date
2025-05-07
Accepted
2025-05-07 16:39:31
Documents
107
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20250331.htm   iXBRL 10-Q 1355291
2 EX-10.1 amrx-2025033110xqexx101xjd.htm EX-10.1 131480
3 EX-31.1 amrx-2025033110xqexx311.htm EX-31.1 10347
4 EX-31.2 amrx-2025033110xqexx312.htm EX-31.2 10264
5 EX-31.3 amrx-2025033110xqexx313.htm EX-31.3 10421
6 EX-32.1 amrx-2025033110xqexx321.htm EX-32.1 5617
7 EX-32.2 amrx-2025033110xqexx322.htm EX-32.2 5563
8 EX-32.3 amrx-2025033110xqexx323.htm EX-32.3 5651
  Complete submission text file 0001723128-25-000022.txt   8896507

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20250331.xsd EX-101.SCH 74282
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20250331_cal.xml EX-101.CAL 93476
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20250331_def.xml EX-101.DEF 320388
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20250331_lab.xml EX-101.LAB 744427
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20250331_pre.xml EX-101.PRE 540487
110 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20250331_htm.xml XML 1376905
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 25922103
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)